Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.
暂无分享,去创建一个
David C Wilson | Jack Satsangi | Richard K Russell | H. Drummond | E. Nimmo | J. Satsangi | R. Russell | I. Arnott | J. V. van Limbergen | P. Mcgrogan | P. Gillett | Elaine R Nimmo | Marian C Aldhous | Johan Van Limbergen | L. Weaver | M. Aldhous | G. Mahdi | Lawrence T Weaver | Hazel E Drummond | Nicola K Round | Linda Smith | Peter M Gillett | Paraic McGrogan | W Michael Bisset | Gamal Mahdi | Ian D Arnott | D. Wilson | J. V. Limbergen | W. Bisset | D. Wilson | L. Smith | Nicola K. Round
[1] R. Hoffmann,et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.
[2] M. Vatn,et al. Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study) , 2007, Scandinavian journal of gastroenterology.
[3] A. Griffiths. Specificities of inflammatory bowel disease in childhood. , 2004, Best practice & research. Clinical gastroenterology.
[4] A. Griffiths,et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. , 2007, Gastroenterology.
[5] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.
[6] Geraint T. Williams,et al. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996–2005 , 2007, Alimentary pharmacology & therapeutics.
[7] B. Sandhu,et al. Presenting features of inflammatory bowel disease in Great Britain and Ireland , 2003, Archives of disease in childhood.
[8] Athos Bousvaros,et al. The Crohn’s and Colitis Foundation of America , 2018, The Grants Register 2019.
[9] J. Markowitz,et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. , 2000, Gastroenterology.
[10] D. Jewell,et al. A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.
[11] J. Hugot,et al. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. , 2005, Journal of pediatric gastroenterology and nutrition.
[12] J. Satsangi,et al. Crohn’s disease or Crohn’s diseases? , 2003, Gut.
[13] A. Griffiths,et al. Methotrexate Following Unsuccessful Thiopurine Therapy in Pediatric Crohn's Disease , 2007, The American Journal of Gastroenterology.
[14] J. Belaiche,et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease , 2001, Gut.
[15] A. Latiano,et al. Polymorphisms of Tumor Necrosis Factor-α but Not MDR1 Influence Response to Medical Therapy in Pediatric-Onset Inflammatory Bowel Disease , 2007, Journal of pediatric gastroenterology and nutrition.
[16] R. Baker,et al. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England , 2003, European journal of gastroenterology & hepatology.
[17] Mark Avigan,et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. , 2007, Journal of pediatric gastroenterology and nutrition.
[18] N. LeLeiko,et al. Distinct Phenotype of Early Childhood Inflammatory Bowel Disease , 2006, Journal of clinical gastroenterology.
[19] J. Witte,et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). , 2000, Scandinavian journal of gastroenterology.
[20] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[21] R. Baldassano,et al. Inflammatory bowel disease in children 5 years of age and younger , 2002, American Journal of Gastroenterology.
[22] Joseph T. Glessner,et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn’s disease , 2007, Gut.
[23] H. Drummond,et al. Disease Location, Anti-Saccharomyces cerevisiae Antibody, and NOD2/CARD15 Genotype Influence the Progression of Disease Behavior in Crohn’s Disease , 2004, Inflammatory bowel diseases.
[24] J. Satsangi,et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.
[25] J. Belaiche,et al. Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype , 2003, Gut.
[26] R. Baldassano,et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. , 2005, The Journal of pediatrics.
[27] M. Vatn,et al. Ulcerative colitis and clinical course: Results of a 5‐year population‐based follow‐up study (the IBSEN study) , 2006, Inflammatory bowel diseases.
[28] H. Drummond,et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland , 2001, European journal of gastroenterology & hepatology.
[29] H. Drummond,et al. 1043 The Efficacy of Corticosteroid Therapy: Analysis of 10-Year Inflammatory Bowel Disease Inception Cohort (1998-2007) , 2008 .
[30] F. Carbonnel,et al. Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.
[31] B. Koletzko,et al. ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition - Annex: List of Products , 2005, Journal of pediatric gastroenterology and nutrition.
[32] Stefan Schreiber,et al. Diagnostics of inflammatory bowel disease. , 2007, Gastroenterology.
[33] R. Baldassano,et al. Gender Differences in Presentation and Course of Disease in Pediatric Patients With Crohn Disease , 2007, Pediatrics.